封面
市場調查報告書
商品編碼
1672800

全球合成生物學市場按產品、技術、最終用戶和地區分類

Synthetic Biology Market, By Product, By Technology, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球合成生物學市場規模預估為 219 億美元,預計到 2032 年將達到 907.3 億美元,2025 年至 2032 年的複合年成長率為 22.5%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 219億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025-2032年複合年成長率: 22.50% 2032 年價值預測 907.3億美元
數字。 2025 年合成生物學市場佔有率(按地區分類)
合成生物學市場-IMG1

合成生物學是將工程原理應用於生物學的新興領域。該領域涉及新型人工生物路徑、生物體和設備的設計和構建,或對現有的自然生物系統的重新設計。合成生物學的主要應用包括開發燃料、化學品和材料的先進生物製造技術,以及開發用於農業、製藥和環境解決方案的工程生物。研究人員正在致力於開發人工生物系統,以實現更有效率、更環保的生產過程。 DNA序列測定、基因組裝和編輯技術的進步推動了該領域的快速發展,有可能解決醫療保健、能源和環境等領域的許多緊迫的全球挑戰。

市場動態:

全球合成生物學市場受到該領域研發資金和投資增加、DNA定序和基因編輯技術的進步、生物製藥需求不斷成長以及代謝工程等技術發展等因素的推動。行業標準正在製定中,以確保合成生物學的負責任且安全的應用。然而,有關基因改造生物的監管問題和道德問題可能會抑制市場成長。合成生物學為解決藥物發現、工業生物製造和環境修復等多個領域的挑戰提供了機會。商業應用的發展、國際合作以及 DNA 合成和基因組工程成本效益的提高將支持市場擴張。

本研究的主要特點

  • 本報告對全球合成生物學市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模和複合年成長率。
  • 它還揭示了不同領域的潛在收益成長機會,並說明了該市場的引人注目的投資提案矩陣。
  • 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
  • 報告根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數,涵蓋了全球合成生物學市場主要企業的概況。
  • 本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
  • 全球合成生物學市場報告涵蓋該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
  • 相關人員可以透過用於分析全球合成生物學市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件

第2章 市場概況

  • 報告描述
    • 市場定義和範圍
  • 執行摘要
  • 市場機會藍圖

第 3 章 關鍵見解

  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 影響分析
  • PEST分析
  • 波特的分析
  • 技術進步
  • 併購與合作場景
  • 近期產品核可
  • 進出口分析
  • 監管情景
  • 定價分析
  • COVID-19影響分析
  • 生產能力
  • 經銷商狀況
  • 投資與資金籌措
  • 品牌地圖
  • 競爭概況
  • 公司定位分析
  • 熱圖分析

第 4 章。全球合成生物學市場依產品分類(2020-2032 年)

  • 寡核苷酸
  • 酵素
  • 合成細胞
  • 底盤有機體
  • 其他

5. 全球合成生物學市場依技術分類(2020-2032 年)

  • 基因組工程
  • PCR 技術
  • 生物程序技術
  • NGS技術
  • 生物資訊學
  • 奈米科技
  • 其他

6. 全球合成生物學市場依最終用戶分類(2020-2032 年)

  • 製藥公司
  • 生技公司
  • CMO 和 CRO
  • 其他

7. 全球合成生物學市場按地區分類(2020-2032 年)

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東
  • 非洲

第8章 競爭格局

  • 衝突的簡介
  • 市場公司觀點
  • 競爭儀錶板
  • 企業市場佔有率分析:全球(2025 年)
  • 公司簡介:全球合成生物學市場
  • Thermo Fisher Scientific
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs(UK)Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

第 9 章 命運之輪

  • 命運之輪
  • 分析師觀點
  • Coherent Opportunity Map(COM)

第10章參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI112

Global Synthetic Biology Market is estimated to be valued at USD 21.90 Bn in 2025 and is expected to reach USD 90.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 21.90 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 22.50% 2032 Value Projection: USD 90.73 Bn
Figure. Synthetic Biology Market Share (%), By Region 2025
Synthetic Biology Market - IMG1

Synthetic biology is an emerging field that applies engineering principles to biology. It involves the design and construction of novel artificial biological pathways, organisms or devices or the re-design of existing natural biological systems. Some key applications of synthetic biology include development of advanced biomanufacturing techniques for fuels, chemicals and materials as well as development of engineered organisms for agriculture, pharmaceuticals and environmental solutions. Researchers are working towards developing engineered biological systems for more effective and environment-friendly production processes. Advancements in DNA sequencing, gene assembly, and editing techniques have enabled rapid progress in the field with the potential to address many pressing global challenges in healthcare, energy, and environment.

Market Dynamics:

The global synthetic biology market is driven by factors such as increasing R&D funding and investment in the field, advancements in DNA sequencing and gene editing technologies, rising demand for biopharmaceuticals, and development of techniques like metabolic engineering. Industry standards are being developed to ensure the responsible and safe application of synthetic biology. However, regulatory issues relating to genetically engineered organisms and ethical concerns could potentially restrain the market growth. Synthetic biology offers opportunities to address challenges in several sectors like drug discovery, industrial biomanufacturing, and environmental remediation. Development of commercial applications, international collaborations, and improved cost efficiencies in DNA synthesis and genome engineering will support market expansion.

Key Features of the Study:

  • This report provides an in-depth analysis of the global synthetic biology market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global synthetic biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study includes Thermo Fisher Scientific, Synbio Technologies, Merck KGaA, Agilent Technologies Inc., GenScript, Amyris, Eurofins Genomics GmbH, Integrated DNA Technologies Inc., Codexis Inc., EnBiotix Inc., Synthego, New England Biolabs (UK) Ltd., Scarab Genomics LLC , Genomatica Inc., Novonesis Group, Bota Bio, Creative Biogene, and Illumina, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global synthetic biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global synthetic biology market.

Market Segmentation

  • Product:
    • Oligonucleotides
    • Enzymes
    • Synthetic Cells
    • Chassis Organism
    • Others
  • Technology:
    • Genome Engineering
    • PCR Technology
    • Bioprocessing Technology
    • NGS Technology
    • Bioinformatics
    • Nanotechnology
    • Others
  • End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • CMO & CRO
    • Others
  • Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific
    • Synbio Technologies
    • Merck KGaA
    • Agilent Technologies Inc.
    • GenScript
    • Amyris
    • Eurofins Genomics GmbH
    • Integrated DNA Technologies Inc.
    • Codexis Inc.
    • EnBiotix Inc.
    • Synthego
    • New England Biolabs (UK) Ltd.
    • Scarab Genomics LLC
    • Genomatica Inc.
    • Novonesis Group
    • Bota Bio
    • Creative Biogene
    • Illumina, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Technology
    • Market Snapshot, By End User
    • Market Snapshot, By Region
    • Market Scenario - Conservative, Likely, Opportunistic
  • Market Opportunity Map

3. Key Insights

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Pest Analysis
  • Porters Analysis
  • Technological Advancement
  • Merger, Acquisition and Collaboration Scenario
  • Recent Product Approvals
  • Import-Export Analysis
  • Regulatory Scenario
  • Pricing Analysis
  • COVID-19 Impact Analysis
  • Manufacturing Capacities
  • Distributors Landscape
  • Investments & Funding
  • Brand Mapping
  • Competitive Snapshot
  • Company Positioning Analysis
  • Heat Map Analysis

4. Global Synthetic Biology Market, By Product, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Oligonucleotides, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Enzymes, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Synthetic Cells, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Chassis Organism, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

5. Global Synthetic Biology Market, By Technology, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Genome Engineering, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • PCR Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Bioprocessing Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • NGS Technology, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Bioinformatics, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Nanotechnology , 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

6. Global Synthetic Biology Market, By End User, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032
    • Market Y-o-Y Growth Comparison (%), 2020 - 2032
    • Segment Trends
  • Pharmaceutical Companies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Biotechnology Companies, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • CMO & CRO, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)
  • Others, 2020 - 2032(US$ Billion)
    • Introduction
    • Market Size and Forecast, 2020 - 2032, (US$ Billion)

7. Global Synthetic Biology Market, By Region, 2020 - 2032 (US$ Billion)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (US$ Billion)
    • Market Y-o-Y Growth Comparison (%), 2025 - 2032, (US$ Billion)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • U.S.
    • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest Of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Asean
    • Rest Of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country, 2020 - 2032, (US$ Billion)
    • GCC
    • Israel
    • Rest Of The Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Technology, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By End User, 2020 - 2032, (US$ Billion)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Billion)
    • South Africa
    • North Africa
    • Central Africa

8. Competitive Landscape

  • Competitive Snapshot
  • What Market Participants are Saying?
  • Competitive Dashboard
  • Company Market Share Analysis, 2025 - Global
  • Company Profiles - Global Synthetic Biology Market
  • Thermo Fisher Scientific
    • Company Overview
    • Product/Service Portfolio
    • Financial Performance
    • Recent Developments/Updates
    • Strategic Overview
  • Synbio Technologies
  • Merck KGaA
  • Agilent Technologies Inc.
  • GenScript
  • Amyris
  • Eurofins Genomics GmbH
  • Integrated DNA Technologies Inc.
  • Codexis Inc.
  • EnBiotix Inc.
  • Synthego
  • New England Biolabs (UK) Ltd.
  • Scarab Genomics LLC
  • Genomatica Inc.
  • Novonesis Group
  • Bota Bio
  • Creative Biogene
  • Illumina, Inc.

9. Wheel of Fortune

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact